In vivo, ex vivo and in vitro assessment of buccal permeation of drugs from delivery systems

被引:41
作者
Pinto, Soraia [1 ,2 ]
Pintado, Manuela E. [3 ]
Sarmento, Bruno [1 ,2 ,4 ]
机构
[1] Univ Porto, I3S, Porto, Portugal
[2] Univ Porto, INEB, Porto, Portugal
[3] Univ Catolica Portuguesa, Escola Super Biotecnol, CBQF, Lab Associado, Porto, Portugal
[4] Inst Univ Ciencias Saude, CESPU, Inst Invest & Formacao Avancada Ciencias & Tecnol, Gandra, Portugal
关键词
Oral cavity; drug delivery systems; permeability studies; animal models; ex vivo studies; TR146; CELL-CULTURE; HUMAN ORAL-MUCOSA; PERMEABILITY BARRIERS; TRANSBUCCAL DELIVERY; TISSUE PERMEABILITY; RAMAN-SPECTROSCOPY; LIPID-COMPOSITION; ABSORPTION; MODEL; TRANSPORT;
D O I
10.1080/17425247.2020.1699913
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Buccal mucosa has been described as an attractive site for local and systemic drug delivery, owing its accessibility, safety, and excellent blood supply. The absorption of drugs through buccal mucosa has been assessed by in vivo, ex vivo and in vitro permeability studies, using animal and cell-based models with close resemblance to the human buccal mucosa. Areas covered: This paper focuses on the current in vivo, ex vivo and in vitro permeability studies to analyze the absorption of compounds of interest through buccal mucosa, as well as their advantages and limitations in the preclinical studies of the drugs absorption profiles. The techniques for preparation and preservation of the animal buccal tissue are also discussed to evaluate their interference in the integrity and permeability of the tissues. Expert opinion: Overall, the permeability studies have been useful to evaluate the drugs absorption and to clarify the mechanism of transport of drugs across human buccal mucosa, as well as to explain the enhancement of permeability provided by certain dosage forms. Currently, several researchers have demonstrated particular interest in ex vivo permeability studies, due to their effectiveness in the evaluation of drug absorption and low costs in the acquisition of buccal mucosa samples.
引用
收藏
页码:33 / 48
页数:16
相关论文
共 138 条
[1]  
Adhikari Surya Narayan Ratha, 2017, Polim Med, V47, P5, DOI 10.17219/pim/70498
[2]   Aripiprazole Nanocrystal Impregnated Buccoadhesive Films for Schizophrenia [J].
Al-Dhubiab, Bandar E. .
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2017, 17 (04) :2345-2352
[3]   Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir [J].
Al-Dhubiab, Bandar E. ;
Nair, Anroop B. ;
Kumria, Rachna ;
Attimarad, Mahesh ;
Harsha, Sree .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2015, 136 :878-884
[4]   Will a water gradient in oral mucosa affect transbuccal drug absorption? [J].
Ali, Abdullah ;
Wahlgren, Marie ;
Pedersen, Lina ;
Engblom, Johan .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 48 :338-345
[5]   An improved cryopreservation method for porcine buccal mucosa in ex vivo drug permeation studies using Franz diffusion Cells [J].
Amores, Sonia ;
Domenech, Jose ;
Colom, Helena ;
Calpena, Ana C. ;
Clares, Beatriz ;
Gimeno, Alvaro ;
Lauroba, Jacinto .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 60 :49-54
[6]   Optimization and evaluation of mucoadhesive buccal films loaded with resveratrol [J].
Ansari, Mudassir ;
Sadarani, Bhakti ;
Majumdar, Anuradha .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 44 :278-288
[7]   Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies [J].
Artusi, M ;
Santi, P ;
Colombo, P ;
Junginger, HE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 250 (01) :203-213
[8]   HUMAN BUCCAL ABSORPTION OF FLURBIPROFEN [J].
BARSUHN, CL ;
OLANOFF, LS ;
GLEASON, DD ;
ADKINS, EL ;
HO, NFH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (02) :225-231
[9]   Facilitated permeation of insulin across TR146 cells by cholic acid derivatives-modified elastic bilosomes [J].
Bashyal, Santosh ;
Seo, Jo-Eun ;
Keum, Taekwang ;
Noh, Gyubin ;
Choi, Young Wook ;
Lee, Sangkil .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 :5173-5186
[10]  
Bathi R, 2012, INT J PHARM SCI DRUG, V3, P659